allogeneic iPSC-derived gamma delta CAR-iNK cell therapy (Century Therapeutics)

N/A

Report date: 2025/03/14 16:24:12

Base Information

Drug Nameallogeneic iPSC-derived gamma delta CAR-iNK cell therapy (Century Therapeutics)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionImmunostimulantsNatural killer cells stimulants

TargetsUpdating

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCentury Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesCentury Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A